Eden Biodesign has been acquired by Watson Pharmaceuticals for $15m. Watson had previously acquired 36% of the business through a previous acquisition last year. Following the acquisition Eden will continue to offer contract manufacturing services.
Business Week
Tuesday 2 February 2010
Watson acquires Eden
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment